Contribution of Contrast Enhanced Ultrasound for Diagnosis of Adnexal Torsion

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE3

Total Enrollment

256 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-14

Study Completion Date

2028-02-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adnexal torsion is the rotation of the ovary around its vascular axis resulting, in the absence of treatment, ischemia that can lead to peritonitis by necrosis or impaired fertility. It is a gynecological emergency affecting 3% of women of childbearing age, including from adolescence, and requires surgical treatment as soon as possible, classically within 6 hours.

The symptomatology of adnexal torsion is dominated by pelvic pain of sudden onset and variable intensity, an aspecific sign that does not allow a diagnosis of certainty. There are no biological markers and, in the context of the emergency, the only imaging examination available is pelvic ultrasound associated with a Doppler flow analysis but with a low and variable diagnostic performance depending on the studies (sensitivity variable from 46 to 73%).

There are currently no tests that can provide a diagnosis of certainty. Only surgical exploration, carried out at the discretion of the practitioner on the basis of a bundle of arguments, can confirm or refute the diagnosis. However, this management strategy leads to the realization of emergency surgical interventions wrongly since 3 out of 10 women will finally not have an adnexal torsion (PMSI data from participating centers: 30 to 45% false positives).

Contrast ultrasound is a technique that uses a strict intravascular product to assess the vascularization of the ovary and offers a high diagnostic performance in the context of adnexal torsion. Indeed, a retrospective study, published in 2021, reports a sensitivity of 94% and a specificity of 100%. The preliminary results of our pilot study (AGATA APJC 2019, Dr Bertholdt, NCT04522219) also go in this direction with a sensitivity of 100%, a specificity of 86% and a negative predictive value of 100% (data being published).

The COVARIAN project, second stage of the AGATA project, aims to demonstrate that the addition of a contrast evaluation to standard ultrasound in the diagnostic strategy in case of suspicion of adnexal torsion improves the health of women by reducing the rate of wrongly surgery, that is, without proven torsion.

COVARIAN will be the first prospective multicenter randomized study evaluating the direct benefit for women of using ultrasound contrast evaluation in the management strategy in case of suspicion of adnexal torsion.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Contribution of Contrast Enhanced Ultrasound in the Diagnosis of Adnexal Torsion

NCT04522219

Adnexal Torsion

TERMINATED PHASE3

Ultrasound-guided Transvaginal Aspiration of Cystic Pelvic Lesions

NCT06988280

Pelvic Abscess Adnexal Cyst Ovarian Neoplasms

RECRUITING

Prospective Validation of the ADNEX Model for Discrimination Between Benign and Malignant Adnexal Masses in Pregnancy: International Ovarian Tumour Analysis in Pregnancy Study (p-IOTA)

NCT05974618

Adnexal Mass Adnexal Tumor Adnexal Cyst +1 more

RECRUITING

Prospective Study of the Variation in the Angle of Anteflexion of the Uterus Before and After Micturition in Nulliparous Women With Uterine Anteversion.

NCT06669845

Uterine Anteflexion

COMPLETED NA

Effect of Fetal Ovarian Cyst Aspiration to Prevent Torsion

NCT00222066

Ovarian Cyst Ultrasonography Prenatal

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adnexal Torsion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ultrasound with contrast injection

Patients consulting the gynecological emergencies as part of the management of a strong suspicion of adnexal torsion (after the clinical examination and standard ultrasound)

Group Type EXPERIMENTAL

Addition of ultrasound with contrast injection (SonoVue®)

Intervention Type DRUG

Addition of contrast evaluation with SonoVue® injection (5 min including 1 min of acquisition) within the diagnostic strategy

Control

Patients consulting the gynecological emergencies as part of the management of a strong suspicion of adnexal torsion (after the clinical examination and standard ultrasound)

Group Type ACTIVE_COMPARATOR

Standard Care (in control arm)

Intervention Type OTHER

No addition of ultrasound with contrast

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Addition of ultrasound with contrast injection (SonoVue®)

Addition of contrast evaluation with SonoVue® injection (5 min including 1 min of acquisition) within the diagnostic strategy

Intervention Type DRUG

Standard Care (in control arm)

No addition of ultrasound with contrast

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 or over
* Person who has carried out a preliminary clinical examination adapted to the clinical trial
* Strong suspicion of adnexal torsion with surgery planned
* No ongoing pregnancy or breastfeeding
* Affiliation to or beneficiary of a social security scheme
* Person who has received complete information on the organization of the research and has signed their informed consent

Exclusion Criteria

* Person who does not understand and/or speak French
* Any medical situation that does not indicate the administration of SonoVue®, including:

* Known hypersensitivity to sulphur hexafluoride or any of the other components of SonoVue
* Woman with acute coronary syndrome or unstable ischemic heart disease
* Woman with acute endocarditis
* Woman with valve prostheses
* Women with acute systemic inflammatory disease and/or sepsis
* Woman with hypercoagulation and/or recent thromboembolic accident
* End-stage woman with kidney or liver disease
* Woman with right-left shunt, severe pulmonary hypertension (pulmonary arterial pressure \> 90 mmHg)
* Women with uncontrolled systemic hypertension
* Woman with respiratory distress syndrome
* Medical condition contraindicating the administration of SonoVue®,
* History of PEG allergy (or macrogol)
* Person referred to in Articles 10, 31, 32, 33 and 34 of Regulation EU 536/2014:

* Pregnant, parturient or breastfeeding/nursing mother
* Minor (not emancipated)
* Adult subject to a legal protection measure (guardianship, curatorship, safeguarding of justice)
* Person of legal age who is unable to express consent

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

BERTHOLDT Charline

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Charline BERTHOLDT, Pr

Role: PRINCIPAL_INVESTIGATOR

CHRU Nancy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.